Aggressive Marketing Increases Awareness of Stroke as a Leading Cause of Death in Latin America – Driving Rapid Growth in the TEO Market

Waltham, Mass. (PRWEB) October 5, 2006

Millennium Research Group (MRG), the global authority on medical technology market intelligence, has conducted a detailed and thorough analysis of the transcatheter embolization and occlusion (TEO) device market. The analysis reveals that aggressive marketing campaigns are popularizing TEO devices in the emerging markets of Latin America. These markets represent significant profit-making potential for medical device manufacturers. According to the new report entitled Latin American Markets for Transcatheter Embolization and Occlusion Devices 2006, the adoption of new and innovative TEO technologies, particularly in interventional neuroradiology, will be the major driver of revenue in the Latin American market over the next five years.

More than 600,000 strokes occurred in Latin America in 2005, establishing stroke as a leading cause of death. Latin American dominant stroke subtypes appear to be different from those reported in other regions of the world, with a higher frequency of cerebral hemorrhages, small-vessel disease, and intracranial atherosclerotic lesions. Differences in stroke subtypes may be related to genetic, environmental, or sociocultural factors, and to various methods of managing stroke risk factors.

Endovascular coiling, the minimally invasive alternative to surgical clipping, promises short procedure duration, few complications, and reduced recovery time, and is an effective treatment option for cerebral aneurysms. Left untreated, cerebral aneurysm rupture can lead to often-fatal hemorrhagic strokes. The higher incidence of cerebral hemorrhages in Latin America, coupled with the low endovascular coiling penetration rate will result in significant TEO procedure growth.

The Latin American TEO devices market (comprising Argentina, Brazil, Chile, Colombia, Mexico, Puerto Rico, Venezuela, and the Rest of Latin America — Uruguay, Ecuador, Peru, Bolivia, and Paraguay) will increase at a compound annual growth rate of almost 15% over the next 5 years.

MRG’s Latin American Markets for Transcatheter Embolization and Occlusion Devices 2006 report is part of the Global Markets for Transcatheter Embolization series, which includes analysis on Europe. The report covers various key industry competitors, including Boston Scientific (BSX), AGA Medical, Cordis (JNJ), Terumo/Microvention, ev3/MTI (EVVV), Cook, Balt, Micrus Corporation (MEND), BioSphere Medical, B. Braun, and Biocompatibles/Terumo.

About Transcatheter Embolization

Transcatheter embolization is the interventional radiological procedure in which abnormal vessels are closed off with various substances, such as coils, embolic glue, or embolization particles.

About Millennium Research Group

Millennium Research Group (http://www.MRG.net), a Decision Resources, Inc. company (http://www.DecisionResources.com), is a leading provider of strategic information to the health care sector. Focused solely on the medical device, pharmaceutical, and biotechnology industries, the company provides its clients with the benefits of its specialized industry expertise through published reports and customized consulting services.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.

###